9-(3-cyanophenyl)-8-[3-[9-(6-methylcyclohexa-1,3-dien-1-yl)carbazol-1-yl]phenyl]carbazole-3-carbonitrile
C45H30N4 — CID 146185716
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-(3-cyanophenyl)-8-[3-[9-(6-methylcyclohexa-1,3-dien-1-yl)carbazol-1-yl]phenyl]carbazole-3-carbonitrile
9-(3-cyanophenyl)-8-[3-[9-(6-methylcyclohexa-1,3-dien-1-yl)carbazol-1-yl]phenyl]carbazole-3-carbonitrile (PubChem CID 146185716) has the molecular formula C45H30N4 and a molecular weight of 626.76 g/mol. Its IUPAC name is 9-(3-cyanophenyl)-8-[3-[9-(6-methylcyclohexa-1,3-dien-1-yl)carbazol-1-yl]phenyl]carbazole-3-carbonitrile.
Molecular Properties
| Compound Name | 9-(3-cyanophenyl)-8-[3-[9-(6-methylcyclohexa-1,3-dien-1-yl)carbazol-1-yl]phenyl]carbazole-3-carbonitrile |
|---|---|
| PubChem CID | 146185716 |
| Molecular Formula | C45H30N4 |
| Molecular Weight | 626.76 g/mol |
| Exact Mass | 626.25 |
| IUPAC Name | 9-(3-cyanophenyl)-8-[3-[9-(6-methylcyclohexa-1,3-dien-1-yl)carbazol-1-yl]phenyl]carbazole-3-carbonitrile |
| SMILES | CC1CC=CC=C1n1c2ccccc2c2cccc(-c3cccc(-c4cccc5c6cc(C#N)ccc6n(-c6cccc(C#N)c6)c45)c3)c21 |
| InChI | InChI=1S/C45H30N4/c1-29-10-2-4-20-41(29)49-42-21-5-3-15-37(42)38-18-8-17-36(45(38)49)33-13-7-12-32(26-33)35-16-9-19-39-40-25-31(28-47)22-23-43(40)48(44(35)39)34-14-6-11-30(24-34)27-46/h2-9,11-26,29H,10H2,1H3 |
| InChIKey | XOGSKELSIPLBMW-UHFFFAOYSA-N |
| XLogP | 11.41 |
| TPSA | 57.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 626.76 |
| LogP ≤ 5 | 11.41 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146185716 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.